Compare PRQR & ACR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRQR | ACR |
|---|---|---|
| Founded | 2012 | 2005 |
| Country | Netherlands | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 167.5M | 134.4M |
| IPO Year | 2014 | N/A |
| Metric | PRQR | ACR |
|---|---|---|
| Price | $1.72 | $19.06 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 1 |
| Target Price | $6.80 | ★ $24.50 |
| AVG Volume (30 Days) | ★ 406.3K | 15.5K |
| Earning Date | 05-07-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $10.76 | N/A |
| P/E Ratio | ★ N/A | $19.59 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.08 | $16.51 |
| 52 Week High | $3.10 | $24.61 |
| Indicator | PRQR | ACR |
|---|---|---|
| Relative Strength Index (RSI) | 51.70 | 51.27 |
| Support Level | $1.34 | $18.73 |
| Resistance Level | $2.30 | $19.64 |
| Average True Range (ATR) | 0.14 | 0.41 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 61.90 | 43.14 |
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics. Geographically, the company operates in United States.
ACRES Commercial Realty Corp is a commercial real estate investment trust that focuses on originating, holding and managing commercial real estate (CRE) mortgage loans and equity investments in commercial real estate properties through direct ownership and joint ventures. The company invests in commercial real-estate-related assets, including whole loans, A notes, B notes, mezzanine loans, and mortgage-related securities, as well as commercial finance assets, which include other asset-backed securities, senior secured corporate loans, equipment leases and notes, trust preferred securities, debt tranches of collateralize debt obligations, and private equity investments mainly issued by financial institutions.